Merck announced that the FDA has approved Janumet XR (sitagliptin/metformin HCl extended-release tablets) for the treatment of type 2 diabetes. Janumet XR is indicated as an adjunct to diet and ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- New data were presented at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions from a study comparing ...

Insulin is needed less frequently and HbA1c is lowered more robustly when adults with type 2 diabetes do not delay combination therapy but begin treatment by taking sitagliptin and metformin together, ...

The Food and Drug Administration has approved Janumet, a new drug for people with type 2 diabetes. Janumet is approved for use in addition to diet and exercise for patients with type 2 diabetes whose ...

Type 2 Diabetes (T2D) is a major public health challenge, with India ranking second globally in prevalence. [1] The ...

A clinical trial of the glucose-control drug sitagliptin among patients with type 2 diabetes and established cardiovascular disease has found it did not raise the risk of major adverse cardiovascular ...

Objective: To evaluate attainment of diabetes-related quality measures with canagliflozin 100 mg, canagliflozin 300 mg, and sitagliptin 100 mg in patients with type 2 diabetes mellitus. Study design: ...

Objective: To evaluate attainment of diabetes-related quality measures with canagliflozin, a sodium glucose cotransporter 2 inhibitor, versus sitagliptin in patients with type 2 diabetes mellitus ...

Whitehouse Station, NJ - Merck announced on February 2, 2012 that the US Food and Drug Administration (FDA) has approved Janumet XR (sitagliptin and extended-release metformin hydrochloride) tablets ...

JANUMET XR (sitagliptin and metformin HCl extended-release) 50mg/1000mg;100mg/1000mgtablets by Merck Merck announced that the FDA has approved Janumet XR (sitagliptin ...

New data presented at the American Diabetes Association 70 th Annual Scientific Sessions WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- New data were presented at the American Diabetes Association (ADA) ...